BioXcel Therapeutics
BTAI
$3.47
Share price
3.65%
Change (1 day)
-95.42%
Change (1 year)
Categories
P/S ratio for BioXcel Therapeutics (BTAI)
P/S ratio as of April 2025 (TTM): 4.80
According to BioXcel Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.1275. At the end of 2024 the company had a P/S ratio of 11.4.
P/S ratio history for BioXcel Therapeutics from 2018 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 11.4 | -81.81% |
| 2023 | 62.6 | -96.1% |
| 2022 | > 1000 | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |